PB
IBB icon

Pinnacle Bancorp’s iShares Biotechnology ETF IBB Stock Holding History

Pinnacle Bancorp’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$16K Buy
+165
New +$15.8K 0.01% 439

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Pinnacle Bancorp's IBB Position: Q1 2017 in Review

Pinnacle Bancorp opened a new position in iShares Biotechnology ETF (IBB) in Q1 2017: 165 shares worth $16K. The stake represents 0.01% of the portfolio and ranks #439 among its holdings.

520 funds tracked by Wall St. Rank hold IBB as of Q1 2017.

  • Pinnacle Bancorp held 165 shares of iShares Biotechnology ETF worth $16K as of Q1 2017.
  • iShares Biotechnology ETF was a new Pinnacle Bancorp position in Q1 2017.
  • iShares Biotechnology ETF made up 0.01% of Pinnacle Bancorp's portfolio in Q1 2017, its #439 holding.
  • 520 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2017.

Based on Pinnacle Bancorp's 13F filing for Q1 2017, filed 17 Apr 2017.